Navigation Links
Derma Sciences Reports Second Quarter 2008 Results
Date:8/14/2008

PRINCETON, N.J., Aug. 14 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced results today for the second quarter and first six months ended June 30, 2008. Sales were up by 75.4%, reflecting the increased volume and distribution capacity provided by the Company's new First Aid Division as well as the increased sales of its new flagship product, MEDIHONEY(R). For the second quarter in 2008, the company reported sales of $13,083,966, up from $7,461,258 during the same period last year, and continuing an overall upward movement from quarter to quarter.

Commenting on the increases, CEO Ed Quilty said, "Now that the integration is almost complete, we are very excited about the sales and distribution channels that we have created for our new line of products. MEDIHONEY sales were $617,000 for the first two quarters and monthly sales are growing steadily. We sold $152,000 just in the month of July, which is an excellent result for a new dressing. We have two new MEDIHONEY products out on the market and several new products ready to be launched in the months ahead. XTRASORB(TM), our new super-absorbent dressing (which complements the MEDIHONEY products) is due out in September, MOBILITY1(TM), our portable intermittent compression device, will be available in October, and we are in the final phase of preparing to launch a novel off-loading device for diabetic foot ulcers."

Sales were also augmented by Derma Science's expanding sales force, which now numbers thirteen direct sales people, as opposed to only two during the same period last year. Expectations are that the sales force will continue to grow as time taken for a new rep to become profitable is identified, and revenue generated by increased sales of MEDIHONEY and the new product lines help to make the sales force more self-sustaining.

Losses for the second quarter of 2008 were in line with the Company's expectatio
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers
2. Derma Sciences MEDIHONEY(TM) Helps to Save Patients Limb
3. EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board
4. Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced
5. Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis
6. Ferndale and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis
7. EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
8. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
9. Derma Sciences Reports First Quarter 2008 Results
10. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
11. Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... July 12 to take part in the first half of “Integrative Biotechnology,” an ... a partnership established in summer 2014, this course combines students from both universities ...
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell ... next month on his first mission to the International ... from 8 to 9 a.m. EDT Tuesday, July 7. ... in Star City, Russia . The interviews ... NASA Television highlighting his mission training. To schedule ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... provide new insights on mechanics of fecal microbiota transplantation in C. difficile patients. ... the microbiome of patients undergoing fecal microbiota transplantation (FMT) as a treatment for ...
(Date:6/30/2015)... ... 30, 2015 , ... The maximum number of shares proposed to be purchased ... shares of unvested restricted stock). On June 29, 2015, the last trading day prior ... reported on the OTCBB was $2.29 per share. , The tender offer will expire ...
Breaking Biology Technology:Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3
... DIEGO, April 14 XIFIN Inc., the ... diagnostic laboratories, announced today that XIFIN,s CEO ... at the Executive War College Conference in ... attendance will be senior executives, laboratory administrators ...
... to begin after markets close at 2:00 p.m. PT (5:00 ... MASI ), the inventor of Pulse CO-Oximetry and Measure-Through ... first quarter 2009 financial results for the period ended April ... 2009.A conference call to review the results will begin at ...
... N.C., April 14 Pharmaceutical Institute (PI), the ... pharmaceutical and biotech industry, today announced the release ... Markets Excellence(TM) . The series was developed ... leaders from 17 large and midsize pharmaceutical and ...
Cached Biology Technology:XIFIN Inc. CEO to Speak at Executive War College Conference 2XIFIN Inc. CEO to Speak at Executive War College Conference 3Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 2Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 3Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 2Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 3
(Date:6/16/2015)... NEW YORK , June 16, 2015  With ... the world, security remains a top concern. The recent ... confirms the need for strong authentication within government ... HYPR Token, a biometric one-time password (OTP) authenticator, has ... Processing Standards (FIPS) 140-2 Level 3 validation for tamper ...
(Date:6/15/2015)... , June 16, 2015 According ... Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, ... to 2020" published by MarketsandMarkets, The Natural Language Processing ... a CAGR of 18.4% for the forecast period 2015-2020. ...   46 F igures spread   through 155 ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... patent to electronically capture, analyze and identify participants ... recognition methods. This system can: ... an enrollment and subsequent sign-on process is actually ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... and other astute observers of nature have long known that ... the biochemical mechanisms that control this nightly stem elongation, common ... biologistsuntil now. In this week,s early online publication of ... California, San Diego report their discovery of a protein complex ...
... Tel Aviv Stem cells from early embryos can be ... revive and repair different areas of the body. Therapies based ... treatment of diabetes, but have been held back by medical ... are capitalizing on the "memories" of stem cells generated from ...
... Several types of cancer, including stomach, liver and colon, ... scientists have theorized that differences in lifestyle, such as diet ... suggests that the differences are rooted in basic biological differences ... new study from MIT shows that treating male mice with ...
Cached Biology News:Biologists discover an 'evening' protein complex that regulates plant growth 2Biologists discover an 'evening' protein complex that regulates plant growth 3Biologists discover an 'evening' protein complex that regulates plant growth 4Biologists discover an 'evening' protein complex that regulates plant growth 5Stem cell 'memory' can boost insulin levels 2Study explains why men are at higher risk for stomach cancer 2Study explains why men are at higher risk for stomach cancer 3
Biotin d anti-mouse Tim-1...
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
Biology Products: